In Search of the Optimal Heart Perfusion Ultrasound Imaging Platform

Objectives Quantification of myocardial perfusion by contrast echocardiography remains a challenge. Existing imaging phantoms used to evaluate the performance of ultrasound scanners do not comply with perfusion basics in the myocardium, where perfusion and motion are inherently coupled. To contribute toward an improvement, we developed a contrast echocardiographic perfusion imaging platform based on an isolated rat heart coupled to an ultrasound scanner. Methods Perfusion was assessed by using 3 different types of contrast agents: dextran‐based Promiten (Meda AB, Solna, Sweden), phospholipid‐shelled SonoVue (Bracco Diagnostics, Inc, Princeton, NJ), and polymer‐shelled MB‐pH5‐RT, developed in‐house. The myocardial video intensity was monitored over time from contrast agent administration to peak, and 2 characteristic constants were calculated by using an exponential fit: A , representing capillary volume; and β, representing inflow velocity. Results Acquired experimental evidence demonstrates that the application of all 3 contrast agents allows sonographic estimation of myocardial perfusion in the isolated rat heart. Video intensity maps show that an increase in contrast concentration increases the late‐plateau values, A , mimicking increased capillary volume. Estimated values of the flow, proportional to A × β, increase when the pressure of the perfusate column increases from 80 to 110 cm of water. This finding is in agreement with the true values of the coronary flow increase measured by a flowmeter attached to the aortic cannula. Conclusions The contrast echocardiographic perfusion imaging platform described holds promise for standardized evaluation and optimization of contrast perfusion ultrasound imaging in which real‐time inflow curves at low acoustic power semiquantitatively reflect coronary flow.